HIV Virus New treatments in the fight against AIDS were overshadowed by the COVID-19 pandemic but were dramatic. CABENUVA Approval of Cabenuva is the biggest advance in HIV treatment since a daily pill was approved that prevented death from the virus.
The daily pill may now be replaced with a once a month injection. And research continues toward the goal of lengthening the time between injections from one month to two — maybe even longer.
North Texas Infectious Disease Consultants in Dallas is just one of the locations which has been conducting trials for the once-a-month Cabenuva treatments.
Bryan King, vice president of clinical research and business development at NTIDC, said, “Our research department has participated in all the Cabenuva